All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: Lymphoma, Extranodal NK-T-Cell-33242451
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 33242451 E10D
EBNA-1
EBNA-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
2 33242451 H17L
EBNA-1
EBNA-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
3 33242451 T7I
EBNA-1
EBNA-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
4 33242451 I1V
EBNA-1
EBNA-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
5 33242451 L6I
EBNA-1
EBNA-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
6 33242451 I4L
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
7 33242451 L10R
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
8 33242451 L10V
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
9 33242451 L10G
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
10 33242451 L10H
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
11 33242451 E4A
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
12 33242451 T5N
EBNA-2
EBNA-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
13 33242451 I9L
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
14 33242451 F1L
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
15 33242451 I9Q
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
16 33242451 H7R
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
17 33242451 F2S
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
18 33242451 P3L
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
19 33242451 Q8H
EBNA-3A
EBNA-3A
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
20 33242451 A1S
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
21 33242451 A1P
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
22 33242451 V2F
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
23 33242451 V2M
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
24 33242451 V2L
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
25 33242451 I9L
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
26 33242451 R10T
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
27 33242451 K9N
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
28 33242451 A1T
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
29 33242451 Y6D
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
30 33242451 K7E
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
31 33242451 I3L
EBNA-3B/EBNA-3C
EBNA-3B/EBNA-3C
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
32 33242451 D9N
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
33 33242451 V6L
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
34 33242451 A11G
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
35 33242451 L2F
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
36 33242451 M5I
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
37 33242451 E4D
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
38 33242451 Q9P
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
39 33242451 S12T
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
40 33242451 G5S
LMP-1
LMP-1
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
41 33242451 A3G
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
42 33242451 L9I
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
43 33242451 L9F
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
44 33242451 L7F
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
45 33242451 I6M
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
46 33242451 M7V
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
47 33242451 S9T
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
48 33242451 S5T
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
49 33242451 Y9C
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
50 33242451 Y9S
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
51 33242451 Y3C
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
52 33242451 Y3S
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
53 33242451 C1S
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
54 33242451 S4T
LMP-2
Lymphoma, Extranodal NK-T-Cell
G
R
C
L
 View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.